Checkpoint pathways work by detecting DNA damage or incomplete replication and halting cell cycle progression, allowing the cell time to repair the damage. Key proteins involved in these pathways include kinases such as ATM and ATR, which are activated in response to DNA damage. These kinases then activate downstream effectors like CHK1 and CHK2, which in turn inhibit cyclin-dependent kinases (CDKs) and prevent cell cycle progression.
